Length | From 10 to 40 mm |
Diameter | From 1.50 to 4.00 mm |
Nominal pressure | 6 atm |
Rated Burst Pressure | 16 atm |
Guidewire compatibility | 0.014” |
Guiding catheter compatibility |
5F for Ø1.50 to 3.00 mm 6F for Ø3.50 to 4.00 mm 7F for Ø4.00 (length 30, 35 & 40 mm) |
Drug | Paclitaxel |
Excipient | n-Butyryl tri-n-hexyl citrate (BTHC) |
Dosage | 2.5 µg/mm2 |
DEBSIDE Trial: The DEBSIDE clinical trial will enroll 60 patients with bifurcation lesions treated with the DANUBIO drug eluting balloon.
DEBREST Trial: The DEBREST clinical trial will enroll 60 patients with in-stent restenosis lesions treated with the DANUBIO drug eluting balloon.
LENGTH (mm) | DIAMETER (mm) | |||||||||||||
1.50 | 2.00 | 2.25 | 2.50 | |||||||||||
10 | DBCA0001 | DBCA0002 | DBCA0003 | DBCA0004 | ||||||||||
15 | DBCA0009 | DBCA0010 | DBCA0011 | DBCA0013 | ||||||||||
20 | DBCA0017 | DBCA0018 | DBCA0019 | DBCA0020 | ||||||||||
25 | DBCA0025 | DBCA0026 | DBCA0027 | DBCA0028 | ||||||||||
30 | DBCA0033 | DBCA0034 | DBCA0035 | |||||||||||
35 | DBCA0040 | DBCA0041 | DBCA0042 | |||||||||||
40 | DBCA0047 | DBCA0048 | DBCA0049 |
LENGTH (mm) | DIAMETER (mm) | |||||||||||||
2.75 | 3.00 | 3.50 | 4.00 | |||||||||||
10 | DBCA0005 | DBCA0006 | DBCA0007 | DBCA0008 | ||||||||||
15 | DBCA0013 | DBCA0014 | DBCA0015 | DBCA0016 | ||||||||||
20 | DBCA0021 | DBCA0022 | DBCA0023 | DBCA0024 | ||||||||||
25 | DBCA0029 | DBCA0030 | DBCA0031 | DBCA0032 | ||||||||||
30 | DBCA0036 | DBCA0037 | DBCA0038 | DBCA0039 | ||||||||||
35 | DBCA0043 | DBCA0044 | DBCA0045 | DBCA0046 | ||||||||||
40 | DBCA0050 | DBCA0051 | DBCA0052 | DBCA0053 |
Minvasys quality system is ISO 9001 and ISO 13485 certified, hence giving full support to its international partners for local market authorizations. Minvasys devices comply with the requirements of the European Medical Devices Directive 93/42/CEE.
Minvasys
7, rue du Fossé Blanc - 92230 Gennevilliers - France
Tel : +33 (0) 1 47 90 70 30
Fax : +33 (0) 1 47 91 05 85
info@minvasys.com